Craneware PLC
LSE:CRW

Watchlist Manager
Craneware PLC Logo
Craneware PLC
LSE:CRW
Watchlist
Price: 1 526 GBX 0.13% Market Closed
Market Cap: £533.5m

P/FCFE

-41.2
Current
290%
Cheaper
vs 3-y average of 21.7

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
-41.2
=
Market Cap
GBX474.5m
/
Free Cash Flow to Equity
$-16.8m

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
-41.2
=
Market Cap
GBX474.5m
/
Free Cash Flow to Equity
$-16.8m

Valuation Scenarios

Craneware PLC is trading above its 3-year average

If P/FCFE returns to its 3-Year Average (21.7), the stock would be worth GBX-804.48 (153% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-153%
Maximum Upside
No Upside Scenarios
Average Downside
127%
Scenario P/FCFE Value Implied Price Upside/Downside
Current Multiple -41.2 GBX1 526
0%
3-Year Average 21.7 GBX-804.48
-153%
5-Year Average 21.7 GBX-804.48
-153%
Industry Average 0.3 GBX-10.46
-101%
Country Average 0.2 GBX-7.59
-100%

Forward P/FCFE
Today’s price vs future free cash flow to equity

Not enough data available to calculate forward P/FCFE

Peer Comparison

All Multiples
P/FCFE
P/E
All Countries
Close
Market Cap P/FCFE P/E
UK
Craneware PLC
LSE:CRW
540.4m GBP -41.2 30.8
JP
Medical Data Vision Co Ltd
TSE:3902
37.9T JPY 88.6 227.5
US
Cerner Corp
LSE:0R00
31.3B USD 36.2 53.1
US
Veeva Systems Inc
NYSE:VEEV
28.1B USD 20.3 30.9
AU
Pro Medicus Ltd
ASX:PME
14.2B AUD 119.4 60.6
JP
M3 Inc
TSE:2413
1T JPY 23.5 20.5
SE
Sectra AB
STO:SECT B
49.2B SEK 79.2 91.5
US
Doximity Inc
NYSE:DOCS
4.6B USD 15.1 19.3
US
Waystar Holding Corp
NASDAQ:WAY
4B USD 8.6 35
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
283.9B INR -201.6 42.8
CN
Winning Health Technology Group Co Ltd
SZSE:300253
19.1B CNY 80 -62.1

Market Distribution

Lower than 100% of companies in United Kingdom
Percentile
0th
Based on 1 918 companies
0th percentile
-41.2
Low
0 — 0.1
Typical Range
0.1 — 0.4
High
0.4 —
Distribution Statistics
United Kingdom
Min 0
30th Percentile 0.1
Median 0.2
70th Percentile 0.4
Max 901.8

Craneware PLC
Glance View

Market Cap
533.5m GBX
Industry
Health Care

Craneware PLC, a prominent player in the healthcare software industry, crafts its narrative in the pursuit of financial optimization for hospitals across the United States. Established in 1999, Craneware recognized that hospitals were grappling with intricate billing processes and revenue cycle inefficiencies. By focusing on developing comprehensive software solutions, Craneware has strategically positioned itself to help these institutions navigate the labyrinth of medical billing and coding. With its suite of services, including charge capture, pricing analytics, and cost management, Craneware aids hospitals in maximizing their revenue and ensuring compliance. This focus allows healthcare providers to transform data into actionable insights, which not only streamlines operations but also enhances fiscal performance. Revenue generation for Craneware comes primarily from its software sales and accompanying support services. The company employs a Software as a Service (SaaS) model, wherein clients subscribe to its offerings on a recurring basis, ensuring a steady inflow of income while fostering long-term business relationships. This model capitalizes on the growing demand for cloud-based solutions, providing clients with the flexibility and scalability required in a constantly evolving healthcare landscape. Craneware’s unique positioning at the intersection of healthcare and financial management means its growth is not just dependent on acquiring new clients, but also on deepening engagements with existing ones, providing upgrades and enhancements that serve the ever-changing needs of the healthcare industry.

CRW Intrinsic Value
1 296.78 GBX
Overvaluation 15%
Intrinsic Value
Price GBX1 526
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett